The Harley Street Journal

Bi-monthly newspaper for the cosmetic and plastic surgery sector

Peer Reviews

The Undeniable Link Between Cosmetic Surgery and Mental Health

by

From May next year, advertisements for cosmetic procedures designed to change a person’s physical appearance are to be banned to safeguard younger generations struggling with body image pressures. 

In 2019, more than 27 thousand surgeries were carried out in the UK alone; but alongside that, mental health figures are on the rise. Statistics from 2021 show that 1 in 4 people in the UK have been diagnosed with a mental health ailment, and 21% of those are aged between 10 and 19. 

Hagen Schumacher, a leading Plastic Surgeon from Adore Life in London explores how unachievable aspirations have become toxic, and why mental health cannot go ignored in the cosmetics industry. 

In October of this year, a law was enforced to prohibit practitioners from carrying out Botox and facial filler procedures on anybody under the age of 18. Hagen believes that social media has ultimately changed the perception of cosmetic procedures, making it crucial for practitioners to acknowledge the undeniable correlation between plastic surgery and mental health.  

“Previously, cosmetic procedures have been perceived as vanity, it is much more widely accepted. One of the main contributing factors to this wider acceptance is social media, which has painted a false and unattainable body image. I believe aspirations to fit the social media narrative is one of the main driving forces behind the sharp rise in mental health cases, particularly among the younger generation. 

Now, there is an undeniable link between cosmetic surgery and mental health. This puts a lot of emphasis on practitioners to understand and identify the psychological reasons behind patients opting for surgery.”

Studies show that the unrealistic expectations and beauty standards created by social media are the driving force behind patient insecurities. On average, 91% of 16 – 19-year-olds are heavily active on social media, spending around 136 minutes per day on any given platform, and multiple studies have shown that there is a very strong correlation between depression and social media use. 

Hagen adds: “I am not a mental health expert, but my feeling is that there is more focus on appearance within younger generations. They have grown up in a world heavily dominated by social media; and the constant comparisons, have distorted reality, making people feel insecure and therefore more vulnerable.

It is important for young people to realise that certain parts of the body continue to change into adulthood. Whilst cosmetic surgery has come a long way, it is still a serious medical procedure that carries significant risks and severe complications including infection, nerve, and organ damage, scarring, and anaesthesia complications, which could lead to strokes, heart attacks or death in extreme circumstances.

Legally, young people from the age of 16 can consent to medical procedures without the express permission of parents or carers. My personal preference is to wait until the patient is 18 years of age unless the patient’s concern poses a significant problem that is unlikely to improve on its own. 

Before agreeing or carrying out a procedure on somebody under the age of 18, I would first seek the support of parents, and the patient’s GP, and I would ensure each party fully understands the procedure and any risks. Furthermore, I will have an open discussion with the patient to find out exactly how their concern affects them, what they are hoping to achieve with surgery, and explain all risks and complications that may arise”. 

Hagen believes that the initial consultation process is crucial for practitioners to understand a patient’s concerns and identify any potential mental health ailments that may be influencing the decision. 

“When seeing a patient for the first time, I will ask several questions to help me identify any deep rooted mental health issues that may need addressing including medical history, body dysmorphia, and bipolar disease.

In instances where I believe surgery would benefit the patient, but there is a history of mental health issues I would seek opinions from the patient’s mental team, and GP to find out if they feel that patient can firstly make an informed decision about surgery, and secondly, if they feel that patient could cope with any adverse outcome or complication. If there is any doubt in my mind, I will not operate.”

The new regulations will place a ban on ads, including aspirational ads across all media including social media sites, billboards, and posters, newspapers, magazines, and radio as well as influencer marketing aimed, or likely to appeal to under 18’s.

Hagen explains that whilst this move will help to safeguard young people against unrealistic body image pressures, it will not stop patients seeking procedures.

“For years, professional bodies, including The Committee of Advertising Practice (CAP) 

have tried regulating this sector, but it has proven very difficult. These regulations may help alleviate anxieties around body image by providing patients with professional and realistic advice based on their needs rather than on business considerations. It will however not stop and should not stop people seeking surgeries for serious concerns that impact the overall quality of life. 

I urge all practitioners to understand why mental health cannot go ignored, and set out to give patients clear, concise, and honest information about the procedure. There also needs to be more education around industry titles and descriptions, so patients can make an informed decision on the best practitioner to help them and their individual needs, I think there is a lot of confusion around plastic surgeons, and cosmetic surgeons differ, and the specific training programs and requirements needed in each field.”

BAPRAS Members Survey Results Revealed

by

BAPRAS Members Survey Results Revealed

Back in June, BAPRAS members were given the opportunity to take part in a survey to ascertain what led them to choose a career in plastic surgery and what they like and dislike about working within this specialty.

The survey was shared initially at this year’s BAPRAS Summer Scientific Meeting in Bournemouth, and subsequently included on the website, in the Secretariat bulletin, on social media and was distributed to members as a standalone email. 

The total number of respondents included in this analysis is 132, 95 of whom were male and 35 of whom were female. 

While this provided a large enough sample for analysis by gender, there was unfortunately not enough variety across different professional levels to allow robust analysis between those categories. 

The results can be found in more detail below.

Variety of Work

The most commonly listed reason to go into plastic surgery was variety of work (83%), which was also the most common response (39%) when respondents were asked for their single biggest motivation. In fact, more than four in five (87%) surveyed engaged in more than one sub-specialism, with almost two in five (37%) engaged in more than five types of work. At least 92% of those surveyed engaged in some form of non-aesthetic/cosmetic work.

Perceptions of gender dynamics within aesthetic & reconstructive plastic surgery

‘Female role models in a range of senior positions’ was more associated with plastic surgery than other specialisms (33% to 14%), as was ‘parity of pay opportunities regardless of gender’ (23% to 11%), and ‘being valued and respected in the workplace’ (28% to 17%). Furthermore, 46% of women said that role models working in the specialism had motivated them to choose plastic surgery.  

More than a quarter of female members surveyed (27%) felt that there was a more supportive working environment in plastic surgery, compared to 24% who felt it was better in other specialisms. However, allowing the flexibility to balance one’s work and personal life came out much higher for other specialisms than plastic surgery (15% to 41%).

Motivations to go into plastic surgery

The top reasons for pursuing a career in plastic surgery were variety of work (83%), followed by the opportunity to improve lives (61%), and the opportunity to work with different specialisms (52%). When asked to pick their single biggest motivation, the same two came out highest, followed by role models in the specialism (10%).

Male members appeared more motivated by the opportunity to develop innovative techniques than women (53% vs. 38%) and the level of pay (15% of men, 0% of women), whereas female members were more motivated by the opportunity to work with different specialisms (62%) and the opportunity to improve lives (76%).

Level of pay (11%), supportive working environment (10%), the opportunity to save lives (8%), and flexible working (3%), were selected as motivation by the smallest number.

Stages at which members chose this specialism

 Over a third (34%) of those surveyed said that they had made the decision to go into plastic surgery while at medical school. Around 16% said that they had made their decision after starting their career in a different specialism, and 11% had already decided prior to their medical degree. 

Female members tended to make the decision to go into plastic surgery earlier than their male counterparts – with 62% of women saying they had chosen the specialism before they had left medical school, compared to only 38% of men.

Applications launched for the BACN/Church Pharmacy Bursary Awards

by

The BACN and Church Pharmacy formally launch the application process for the BACN/Church Pharmacy Bursary Awards.

There are a number of bursaries available which provide financial awards to BACN members who are considering undertaking the V300 Independent Prescribing qualification, whilst also offering bursaries for those who are understanding ‘Innovative research within the aesthetics speciality.’

Full members are able to apply for these bursaries now.

All applications must be sent to Gareth Lewis, BACN Membership and Marketing Manager at glewis@bacn.org.uk.

4T Medical launches the Dual Injector Pro+

by

Aesthetic product supplier 4T Medical has launched the Dual Injector Pro+ across the UK. 

The Dual Injector Pro+ is a device that delivers both skin tightening/lifting RF technology to boost skin rejuvenation, with electroporation – also known as needle free mesotherapy – a technology that embeds active ingredients like hyaluronic acid deep into the skin without the use of needles.

The unique combination of RF lifting + electroporation enables a client/patient to receive a multi-technology treatment which maximizes the impact and effectiveness of both technologies – giving instant and visible results without the skin trauma that a needle based service could cause.

The RF technology facilitates the attribution of oxygen in the tissues, activates cell metabolism, contributes to the excretion of catabolic residues and stimulates collagen, elastin and hyaluronic acid formation in the skin. 

The Dual Injector Pro+ uses bipolar rather than monopolar RF – which has a shallower reach into the skin layers and offers less risk of burning.

With Electroporation an electromagnetical pulse temporarily disrupts skins intercellular electrical connections so that applied therapeutic substances and preparations can be absorbed deep into the skin layers non-invasively. 

This dual approach visibly improves many common skin complaints from wrinkles and lines, to hyperpigmentation and oily or dry skin. All resulting in tighter, rejuvenated and evenly toned skin almost instantly. 

Julien Tordjmann, Managing Director at 4T Medical commented: “The Dual Injector Pro+ ticks so many boxes for our customers – being a non-invasive needle-free device, delivering instant results, the latest in RF + Electroporation technology and at an attractive price point that can promote a speedy ROI. It adds great value to the 4T Medical offering to our customers and we are delighted to launch it into the UK.”

Celluma Certified Training Now Available in the UK

Celluma Light Therapy is pleased to announce that Celluma training is now available in the UK.

It has been developed in partnership with The Wynyard Aesthetic Academy LLP, a Training Qualification UK Centre registered with the CPD Accreditation Group to deliver accredited training programmes. 

Celluma training has been written to Level 4 in accordance with the UK National Qualification Credit Framework and it carries 60 learning credits.

UK’s stem cell bank say cosmetic surgery could be dramatically improved with the use of stem cells

by

Experts say that penis enlargement, along with a host of other cosmetic surgical procedures, can be significantly aided by using tissue grown from stem cells, which is the same as the body’s own natural material.

This new age of ‘plastic’ surgery will, say the UK’s stem cell bank StemProtect.co.uk, use no synthetic or harmful materials at all, and will instead be done using exclusively cells grown from the cells people can store in stem cell banks.

A combination of fat collected via liposuction, and healthy stem cells from a patient’s own body, can provide a new form of penis, breast and bottom augmentation that far surpasses any kind of enhancement surgery available before.

The benefits for patients are many. As it’s taken from the patients themselves, the body is far less likely to reject the material used for the enhancements. This makes surgery a much less risky procedure for patients, and could improve recovery times as well as making the results look much more natural than alternatives.

And in addition, the augmented parts will age better than synthetic materials and are less likely to need correcting at any point in the future.

In previous years, some patients who have undergone breast augmentation have hit the headlines when their implants have leaked or even exploded, causing health problems as well as a great deal of distress.

A spokesperson for StemProtect.co.uk said: “We’re entering a new age of cosmetic surgery, one which is striving to not only look more natural than ever before, but which is also seeking to use more and more natural materials and procedures to achieve the finished look.

“People are now very aware that natural is better, but at the same time they want to improve their appearance wherever they can. The result is something that stem cells can really help with, growing tissue from a person’s own cells so that it’s not rejected by the body.

“Nowhere is this more useful than in complicated and sensitive surgeries such as penis enlargement. Anything other than natural tissue is always a big risk, but with stem cells you can effectively just improve on nature using all the original materials.”

The same process can also be used to make breasts and bottoms bigger, both procedures that are increasingly becoming commonplace as people take advantage of the falling cost of cosmetic surgery.

In a survey carried out by StemProtect.co.uk, 95% of those surveyed said they would consider stem cell procedures over traditional plastic surgery if they were to choose one of the two in the future.

Sarah, 29, is currently considering a breast augmentation and is researching her options. She said: “I’m being really careful and not rushing into booking anything just yet. Your health is really important, so even though I do want the procedure I want it to be as safe as possible.

“The idea that I could use my own cells instead of adding anything else into my body is really appealing and I’m tempted to wait for that option before I actually get it done.”

Sarah and those like her may not have long to wait. With stem cells being hailed as the potential answer to health problems from ageing to hereditary disease, it’s no wonder they’re also now being explored as an alternative to cosmetic procedures too.

Industry Insider: Gary Ross

by

The Harley Street Journal meets Manchester-based plastic surgeon Mr Gary Ross to discover how the cosmetic surgery industry has evolved this year.

THSJ: As the leader of a successful private clinic, would you say this year has been a positive one for the industry?

GARY: The increased awareness of the need for patient safety has dominated 2017 and has been a positive year for the industry. We are seeing more of a focus on patient empowerment and ensuring patients are fully informed to proceed or not which is imperative for the industry and most importantly for patients.

THSJ: What trends have you seen come to the forefront, and which procedures are on the downturn?

GARY: Overall non surgical procedures have again increased as patients look for cosmetic treatments with less downtime. This has also led to patients looking for surgical procedures with shorter recovery times. Surgically the largest rise / trend has been in the mummy makeover procedure with patients requesting body and breast rejuvenation as a one stage procedure. There has been a downward trend in patients requesting buttock augmentation as compared to a year ago as patients consider more the pros and cons of the procedure. Breast augmentation remains the most requested surgical treatment although patients are currently looking for more subtle enhancements than a year ago.

THSJ: Have you seen any changes within the industry this year that you feel have been a step forward?

GARY: The updated General Medical Council recommendations in relation to consent have highlighted the need for clinicians to ensure patients are fully informed. The adaption of the certification scheme in cosmetic surgery in 2017 through the Royal College of Surgeons (RCS) has developed the speciality of cosmetic surgery. This will allow patients to choose a cosmetic surgeon that is able to fully inform patients regarding the available options so that they are fully empowered to proceed or not.

THSJ: Are we any further forward with regards to regulation within the cosmetic surgery and non-surgical treatment landscapes?

GARY: The Nuffield Council on Bioethics, an independent body that examines and reports on ethical issues in medicine has highlighted in 2017 the need for better regulation of the cosmetic industry and the affect of a negative body image on society in general. Health Education England continues to develop a way forward in the regulation of non surgical treatments and we look forward to further regulatory developments in non surgical treatments in 2018. The certification scheme in cosmetic surgery through the RCS in 2017 has been a major development for patients looking for surgical treatments and we hope that patients will take time to find those clinicians that have opted to be part of this regulatory framework.

THSJ: What has been your professional highlight of 2017?

GARY: Becoming the first cosmetic surgeon to be have completed the Royal College of Surgeons Cosmetic Surgery Certification Scheme was a great honour for me.

THSJ: Do you have any hopes with regards to how the cosmetic landscape may change next year?

GARY: I hope that the focus on patient empowerment continues in 2018 with clinicians focusing increasingly on patient’s interests.

THSJ: What cosmetic beauty trends do you think we’ll see in 2018, and are there any procedures you expect to become more popular?

GARY: In 2018 there will be an increasing trend towards individualised and personalised beauty with a shift away from the “one product/treatment fits all”. The shifting focus in skincare, make-up and fragrance brands towards individualised care will lead to a more holistic approach towards cosmetic beauty.

Profile: Mr Gary Ross

Mr Gary Ross is a plastic, reconstructive and aesthetic surgeon in the North West of England and offers an individualised range of plastic and cosmetic surgery treatments to enhance appearance. He consults and operates at the BMI Alexandra hospital in Cheshire, Manchester. A member of BAAPS and BAPRAS, he is a fully accredited plastic surgeon on the General Medical Council’s specialist register for plastic surgery. Mr Ross is also an Honorary Senior Lecturer University of Manchester and is dedicated to teaching, training and mentorship.

He has published extensively both nationally and internationally comprising over 100 peer reviewed articles and several book chapters (including face lifts, brow lifts, blepharoplasty plus more).

Mr Ross is actively involved in teaching both undergraduate Medical Students and postgraduate Plastic Surgical Trainees through his role as honorary senior clinical lecturer. He has also helped to develop the MSc in Skin Ageing through the University of Manchester and regularly teaches and trains in aesthetic medicine and surgery.

Product in Focus: Nithya Injectable Collagen

by

Discover the latest collagen boosting injectable from Vida Aesthetics, Nithya.

Nithya: the basics

From the age of 25, we lose up to 1.5% of collagen from our skin each year. The resulting appearance of wrinkles due to the loss of our natural collagen can be mitigated by replenishing it and this can now be achieved through treatment with injectable collagen, a product designed for the regeneration and reconstruction of tissues.

Nithya collagen is produced from equine Achilles tendon tissue in a sterile environment. Nithya is a Type I collagen powder which stimulates the production of new fibroblasts to create native Type III collagen during the immunodefense responses triggered by the cell regeneration process known as mechanotransduction, a process that is fundamental in cosmetic medicine and anti-aging treatments.

When the collagen is native it reduces the presence of free telopeptides, a source of allergenicity, almost to zero. It can be defined native because it preserves the same physical and chemical characteristics typical of collagen in the living organism (same sequence and composition of amino acids, same molecular structure); the collagen protein retains its native triple helix structure and there are no free telopeptides.

The equine collagen of Nithya passed all the cytotoxicity, allergenic and skin irritability tests. The product is safe and doesn’t have any contraindications.

Nithya produces the optimal conditions to restore connective tissue. It supplements dermal bio-revitalization and assists the regeneration of connective tissue in the dermis providing perfect conditions for the physiological neo-formation of collagen and can be used for body and facial chrono- and photo-aging treatments.

nithya-picPackaged in powder form, sterile, pyrogen-free and for single use, Nithya must be placed in suspension immediately before use in WFI (Water for Injection) and Lidocaine at a ratio of a 70mg vial of collagen to 4.5ml of WFI and 0.5ml of Lidocaine. Once in suspension, the product should be used immediately and any remaining following the treatment should be discarded.

Using the appropriate size needles from 32G x 2 mm up to 30G x 4 mm, the product is administered through intradermal infiltration by medical practitioners licensed to carry out such treatments. The technical skill of the practitioner is key to the success of the treatment so it is recommended that the practitioner receives specific training on the mesotherapy injection technique.

Nithya bears the CE 0373 mark and is manufactured in Italy by Euroresearch. Used in combination with lidocaine, the procedure is virtually painless and is the only commercially available Type I collagen intended for aesthetic use. Equine collagen, produced by Euroresearch, has been used in pad form for more than 20 years for its healing property on skin ulcers, open wounds, scars and pressure sores.

Equine collagen is FDA approved for wound therapy under the brand name BIOPAD. BIOPAD is produced by the same manufacture as Nithya and uses the same collagen source.

What are the advantages to using Nithya equine collagen compared to bovine collagen?

Studies have shown that 3% of the population are allergic to bovine collagen whereas equine collagen has not shown this level of adverse reaction and in fact, no cases of allergic reaction have been reported. Equine collagen is extracted from the tendon whereas bovine collagen is extracted from the hide.

This results in the equine collagen being a higher quality and purer product when compared with bovine collagen. In addition, it is Type III collagen that is extracted from the bovine hide rather than the Type I from the equine tendon. By using Type I to stimulate production of Type III collagen, the body has more control over production and distribution leading to better and longer lasting results.

The allergic reactions caused by bovine collagen are connected to the source and the extraction process. The collagen is usually extracted from the bovine derma which is a less pure source compared to the tendon, therefore during the extraction process the collagen fibre is cut and consequently this frees polypeptides which can cause allergic reactions to bovine collagen.

Equine collagen is a much more popular choice compared to bovine collagen because the amino acid sequence is more like the human one which makes it work much better with the human body and enhances the results from the collagen.

What are the differences between Type I and Type III collagen?

Type I is the most numerous in number among all collagen types. It can be found in bones, skin and intervertebral disks. It can also be found in scar tissue.

Type III is the second most abundant collagen in the body. It is closely related to collagen Type I in the terms of location and manner of synthesis. It is primarily located in the intestinal walls, muscles and blood vessels, although it can also be found with collagen Type I. Type I and Type III can be mixed together to create supplements for the skin, bone and muscle.

How do you know the animals aren’t infected?

Nithya equine collagen is a bi-product of an established industry. The animals are slaughtered for human consumption and, as with any animal entering the human food chain, are subject to rigorous checks, tests and strict processes. All horses destined for human consumption will have been monitored using a ‘passport’ scheme which will have a complete record of any drugs that have been administered, any indications of recent medications and/or drugs being administered that might render the animal unfit for human consumption.

For more information on Nithya collagen booster injections visit www.vida-aesthetics.com

BTL Aesthetics Wins Best Body Shaping Company 2016

by

Aesthetic device company BTL Aesthetics UK has added another award win to the growing list of accolades, this time from Aesthetic Everything.

The online community voted BTL Aesthetics the Best Body Shaping Company in their 2016, fighting off competition from many other device companies to be crowned the winner.

Offering several innovative radiofrequency-based body contouring devices for the reduction of fat, improvement of cellulite, and skin tightening, BTL Aesthetics continues to offer market-leading devices and award-winning treatments across the world.

Reliable and effective, non-surgical body contouring and shaping treatment is a popular and innovative way to reduce body fat and reshape areas of the body patients may be uncomfortable with.

Thanks to energy assisted fat reduction treatments such BTL Exilis Elite and BTL Vanquish Me, it’s possible to lose inches and reshape the body in a matter of weeks, without the risks associated with surgical options, such as liposuction.

Managing Director of BTL Aesthetics UK, Lee Boulderstone, said:

“This award goes to show the technology behind the body shaping devices available from BTL Aesthetics really work. The results we can achieve for our practitioners and customers speak for themselves, but receiving this accolade from such a highly-regarded and prestigious publication just goes to show the remarkable power of the devices we offer.

“Being a part of the winning team, and seeing our treatments being recognised within the industry like this, is something myself and everyone at BTL Aesthetics UK is truly proud of.

We look forward to meeting new practitioners that wish to integrate our heat-energy devices in to their clinics, as well as supporting our existing customers in the next 12 months and onwards.”

Aesthetic Everything is a networking tool for all members of the aesthetics industry, and includes a magazine as well as online forums.

For more information on the award-winning devices and training programmes offered by BTL Aesthetics UK, please email info@btlnet.com or visit the website btlaesthetics.co.uk

Brand in Focus: HEINE from SurgiSol

by

Available exclusively in the UK from SurgiSol, HEINE’s latest range of headlights and loupes are designed to be flexible and functional.

Why choose HEINE products?

HEINE quality is what generations of doctors have relied on. Every HEINE product – made in Germany – is world leading in terms of precision, ergonomic design and durability, and meets the relevant international standards.

A high-resolution achromatically correct lens system, with edge-to-edge clarity and detail, using ground optical grade glass lenses for precision optics with anti-reflective coatings provides crisp, high-resolution images.

What makes HEINE products such as the loupe industry-leading?

The combination of light and magnification delivers the ultimate in performance as high quality illumination maximises the image quality of the loupe. Featuring LEDHQ illumination for homogeneous illumination with accurate colour rendering that fills the entire field of view from edge-to-edge, the LED LoupeLight is the perfect complement to the 2.5x magnification. All in all, a perfectly matched system with high quality components.

Would you benefit from HEINE’s range?

For those who need a compact, lightweight illumination solution without magnification, we offer the LED MicroLight. Featuring LEDHQ illumination for homogeneous illumination with true and natural colour rendering for every examination situation. Two mounting options offer individuality and easy handling, making the products versatile; illumination without compromises, in a lightweight design.

All of HEINE’s headlight solutions have an adjustable viewing angle over a wide range that provides a completely shadow-free image and coaxial illumination of difficult to see areas. Precision lenses combined with LEDs in HEINE quality provide an absolutely bright light spot that is uniform from edge to edge.

What does the ML4 LED HeadLight offer?

HEINE’s ML4 LED HeadLight with its ergonomic design without compromises has multiple adjustment points for comfort and stability and offers 100% freedom of movement without being tethered to a light source and an adjustable spot size from 30mm to 80mm (at a working distance of 420 mm) to fit any examination situation.

The colour rendering index (CRI) indicates how exact colours are reproduced in comparison with daylight. The ML4 LED HeadLight produces an excellent CRI value of 90, perfect for any tissue work.

Integrated high quality LEDs have a virtually unlimited working life. HEINE LED Headlights are maintenance-free. The battery life is extended by the high efficiency of the LEDs and their low power consumption.

To be able to discern even the slightest abnormalities, it is necessary to properly illuminate the object being examined. It’s not a question of utilising the brightest LED available, but using the right LED and combining it with the optical system of the instrument to achieve the optimum brightness for the examination. This is guaranteed with all of HEINE LEDHQ instruments.

In many diagnostic situations, glare and reflections can be an unwanted byproduct of additional illumination. HEINE have developed a simple but amazingly effective new solution for minimising this problem. Their P2 Polarisation Filter System for their lighting and magnifying loupe combinations, giving you even better views and more detail than before. This new system is available for the ML4 LED Headlight with HR Binocular Loupes and the LED LoupeLight with HR Binocular Loupes.

Why choose the P2 Polarisation Filter System?

The P2 Polarisation filter is a high-performance polarisation system that consists of a filter for the illumination source, as well as 2 filters for your HEINE Binocular Loupes. For example in dentistry, the P2 Polarisation Filter System helps to reduce reflections in the mouth for bright, high contrast and glare free view.

In sclerotherapy/cosmetic procedures, the filter allows direct subsurface visualisation through the superficial skin layers for better visualisation of veins. The HEINE P2 supports dermatologic procedures such as hair follicle examination, spider veins, psoriatic pits (nails), and excision of skin cancer.

In all applications, contrast is improved and reflections minimised. The polarisation filter can also help to accentuate the appearance of inflammation in acne and sun damage. HEINE binocular loupes and illumination – simplifying examinations for the most accurate diagnosis.

For further information on HEINE’s range of headlights and loupes please contact SurgiSol on info@surgisol.com or www.surgisol.com.

Novus Medical Announced As Exclusive WonTech Distributor

by

Medical aesthetic device company Novus Medical is proud to announce its exclusive distribution of WonTech devices.

Novus Medical – launched in 2016 by Jim Westwood – will be the sole supplier of WonTech devices in the UK, marking a big leap for the market-leading device company.

Director Jim praised the union of Novus Medical and WonTech, which was exclusively revealed at the FACE Conference 2016.

“We are pleased to be able to announce our distribution of WonTech under out portfolio of devices at Novus Medical,” said Jim.

“WonTech are renowned for high quality cosmetic devices and products. Developed through their significant research and development team, they have grown the domestic market through quality manufacturing and innovative product design. We’re delighted to be offering UK clinics and salons some market-leading devices,” he said.

WonTech have over 16 years of manufacturing experience for their Q Switched Nd:YAG platform and have created a very stable and high specification Q Switched Nd:YAG device, with over 4 wave lengths.

“The Pastelle is very high quality multi use platform. We have no doubt this will become a top device for clinicians across the country,” said Jim.

WonTech is also the mastermind behind UltraSkin II: one of their leading products. With a significant domestic market share for HIFU, the UltraSkin II is a versatile HIFU device that will offer clinics a broad range of treatments for both body and face.

“The key area for use in the UK will be the face as the device can deliver multi depth coagulation zones enabling a 3 dimensional lifting effect. Results for the UltraSkin II are quick without any need for the client to have anaesthetic,” explained Jim.

“This is in part due to the 1mm focal zone, which reduces pain thus increasing the clients’ satisfaction.  Whilst having a 1mm focal zone is good for facial and neck lifting, it does have limitations for body contouring, as to deliver treatments to the abdomen with a single line delivery at 1mm would lead to lengthy treatment times. Fortunately WonTech have developed the HIFU Body device which launches soon,” Jim concluded.

Due to be launched in the UK later in 2016 – with a grid of 24 x 24 lines versus the 1 line delivery system with most existing HIFU devices – this will ensure effective and quick treatment times for fat reduction of the abdomen and other areas of the body for clients.

“PicoSecond technology is arriving in the UK with WonTech; expected later in Q4 2016, the PicoCare is a multi-wavelength platform. Expected to become one of the most effective and price sensitive pico second lasers, the PicoCare will be attracting lots of attention throughout 2017 and beyond.”

Novus Medical will be offering a scalable model for clinics who wish to be able to offer PicoSecond treatments to their clients.

Utliising their considerable experience in research and design the PicoCare will become a real force in 2017 for Novus Medical.

For more information visit www.novusmedicaluk.com